Multifunctional near-infrared dye-magnetic nanoparticles for bioimaging and cancer therapy

Cancer Letters

Volumn 390, Issue , 2017, Pages 168-175

  Hou, Xiaoyang ^a   Zhou, Huige ^b   Wang, Liming ^b   Tang, Jianqin ^a   Chen, Chunying ^b   Jiang, Guan ^a   Liu, Yanqun ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

Magnetic resonance imaging (MRI); Melanoma; Nanoparticles; Phototherapy; Theranostics

Indexed keywords

CHITOSAN COATED MAGNETIC IRON OXIDE; INDOCYANINE GREEN; IR820; IRON OXIDE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; IR 820; MAGNETITE NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENERGY DISPERSIVE X RAY SPECTROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; LASER; MELANOMA CELL; NEAR INFRARED IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOTHERAPY; PRECIPITATION; THERANOSTIC NANOMEDICINE; TRANSMISSION ELECTRON MICROSCOPY; ANALOGS AND DERIVATIVES; CELL SURVIVAL; CHEMISTRY; HEAT; INFRARED RADIATION; MELANOMA; RADIATION RESPONSE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; CONTRAST MEDIA; FLOW CYTOMETRY; HOT TEMPERATURE; HUMANS; INDOCYANINE GREEN; INFRARED RAYS; MAGNETITE NANOPARTICLES; MELANOMA; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 85010894615     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.12.026     Document Type: Article

References (44)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J. Clin. 65 (2015), 5–29.
2. [2] Xu, P., Xu, N., Guo, K., Xu, A., Takenaka, F., Matsuura, E., et al. Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer. Oncotarget 7 (2016), 33025–33034.
3. [3] Choi, K.Y., Liu, G., Lee, S., Chen, X., Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 4 (2012), 330–342.
4. [4] Fernandez-Fernandez, A., Manchanda, R., McGoron, A.J., Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl. Biochem. Biotechnol. 165 (2011), 1628–1651.
5. [5] Choi, J., Kim, H., Choi, Y., Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer. Quant. Imaging Med. Surg. 5 (2015), 656–664.
6. [6] Zhang, M., Wang, T., Zhang, L., Li, L., Wang, C., Near-infrared light and pH-responsive Polypyrrole@Polyacrylic acid/fluorescent mesoporous silica nanoparticles for imaging and chemo-photothermal cancer therapy. Chemistry 21 (2015), 16162–16171.
7. [7] Zhu, J., Zheng, L., Wen, S., Tang, Y., Shen, M., Zhang, G., et al. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials 35 (2014), 7635–7646.
8. [8] Lukianova-Hleb, E.Y., Oginsky, A.O., Samaniego, A.P., Shenefelt, D.L., Wagner, D.S., Hafner, J.H., et al. Tunable plasmonic nanoprobes for theranostics of prostate cancer. Theranostics 1 (2011), 3–17.
9. [9] Rigon, R.B., Oyafuso, M.H., Fujimura, A.T., Goncalez, M.L., do Prado, A.H., Gremiao, M.P., et al. Nanotechnology-based drug delivery systems for melanoma antitumoral therapy: a review. Biomed. Res. Int., 841817, 2015, 11.
10. [10] Kim, S.B., Lee, T.H., Yoon, I., Shim, Y.K., Lee, W.K., Gold nanorod-photosensitizer complex obtained by layer-by-layer method for photodynamic/photothermal therapy in vitro. Chem. Asian J. 10 (2015), 563–567.
11. [11] Vankayala, R., Lin, C.C., Kalluru, P., Chiang, C.S., Hwang, K.C., Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light. Biomaterials 35 (2014), 5527–5538.
12. [12] Li, P., Shi, Y.W., Li, B.X., Xu, W.C., Shi, Z.L., Zhou, C., et al. Photo-thermal effect enhances the efficiency of radiotherapy using Arg-Gly-Asp peptides-conjugated gold nanorods that target alphavbeta3 in melanoma cancer cells. J. Nanobiotechnol. 13 (2015), 015–0113.
13. [13] Kim, H., Chung, K., Lee, S., Kim, D.H., Lee, H., Near-infrared light-responsive nanomaterials for cancer theranostics. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 8 (2016), 23–45.
14. [14] Yuan, A., Wu, J., Tang, X., Zhao, L., Xu, F., Hu, Y., Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies. J. Pharm. Sci. 102 (2013), 6–28.
15. [15] Wang, L., Lin, X., Wang, J., Hu, Z., Ji, Y., Hou, S., et al. Novel insights into combating cancer chemotherapy resistance using a plasmonic nanocarrier: enhancing drug sensitiveness and accumulation simultaneously with localized mild photothermal stimulus of femtosecond pulsed laser. Adv. Funct. Mater. 24 (2014), 4229–4239.
16. [16] Wang, Y., Black, K.C., Luehmann, H., Li, W., Zhang, Y., Cai, X., et al. Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano 7 (2013), 2068–2077.
17. [17] Hashida, Y., Tanaka, H., Zhou, S., Kawakami, S., Yamashita, F., Murakami, T., et al. Photothermal ablation of tumor cells using a single-walled carbon nanotube-peptide composite. J. Control Release 173 (2014), 59–66.
18. [18] Zhu, B., Sevick-Muraca, E.M., A review of performance of near-infrared fluorescence imaging devices used in clinical studies. Br. J. Radiol., 88, 2015, 20140547.
19. [19] Tang, Y., McGoron, A.J., Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells. J. Photochem. Photobiol. B 97 (2009), 138–144.
20. [20] Lei, T., Fernandez-Fernandez, A., Manchanda, R., Huang, Y.C., McGoron, A.J., Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellular response after laser-induced heating. Beilstein J. Nanotechnol. 5 (2014), 313–322.
21. [21] James, N.S., Chen, Y., Joshi, P., Ohulchanskyy, T.Y., Ethirajan, M., Henary, M., et al. Evaluation of polymethine dyes as potential probes for near infrared fluorescence imaging of tumors: part – 1. Theranostics 3 (2013), 692–702.
22. [22] Grobner, T., Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol. Dial. Transpl. 21 (2006), 1104–1108.
23. [23] Lee, N., Hyeon, T., Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 41 (2012), 2575–2589.
24. [24] Laurent, S., Boutry, S., Mahieu, I., Elst, L., Muller, R., Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr. Med. Chem. 16 (2009), 4712–4727.
25. [25] Wang, Y.X., Zhu, X.M., Liang, Q., Cheng, C.H., Wang, W., Leung, K.C., In vivo chemoembolization and magnetic resonance imaging of liver tumors by using iron oxide nanoshell/doxorubicin/poly(vinyl alcohol) hybrid composites. Angew. Chem. Int. Ed. Engl. 53 (2014), 4812–4815.
26. [26] Zhou, H., Hou, X., Liu, Y., Zhao, T., Shang, Q., Tang, J., et al. Superstable magnetic nanoparticles in conjugation with near-infrared dye as a multimodal theranostic platform. ACS Appl. Mater. Interfaces 8 (2016), 4424–4433.
27. [27] Yameen, B., Choi, W.I., Vilos, C., Swami, A., Shi, J., Farokhzad, O.C., Insight into nanoparticle cellular uptake and intracellular targeting. J. Control Release 190 (2014), 485–499.
28. [28] Melancon, M.P., Elliott, A.M., Shetty, A., Huang, Q., Stafford, R.J., Li, C., Near-infrared light modulated photothermal effect increases vascular perfusion and enhances polymeric drug delivery. J. Control Release 156 (2011), 265–272.
29. [29] Zhang, Z., Wang, L., Wang, J., Jiang, X., Li, X., Hu, Z., et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv. Mater. 24 (2012), 1418–1423.
30. [30] Brys, A.K., Gowda, R., Loriaux, D.B., Robertson, G.P., Mosca, P.J., Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy. Biotechnol. Adv. 34 (2016), 565–577.
31. [31] Hoven, V., Tangpasuthadol, V., Angkitpaiboon, Y., Vallapa, N., Kiatkamjornwong, S., Surface-charged chitosan: preparation and protein adsorption. Carbohydr. Polym. 68 (2007), 44–53.
32. [32] Heneweer, C., Gendy, S.E., Penate-Medina, O., Liposomes and inorganic nanoparticles for drug delivery and cancer imaging. Ther. Deliv. 3 (2012), 645–656.
33. [33] Stylianopoulos, T., EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors. Ther. Deliv. 4 (2013), 421–423.
34. [34] Fortin, J.P., Wilhelm, C., Servais, J., Menager, C., Bacri, J.C., Gazeau, F., Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129 (2007), 2628–2635.
35. [35] Chen, Z., Yin, J.J., Zhou, Y.T., Zhang, Y., Song, L., Song, M., et al. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS Nano 6 (2012), 4001–4012.
36. [36] Kumar, M., Singh, G., Arora, V., Mewar, S., Sharma, U., Jagannathan, N.R., et al. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Int. J. Nanomed. 7 (2012), 3503–3516.
37. [37] Ma, X., Gong, A., Chen, B., Zheng, J., Chen, T., Shen, Z., et al. Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy. Colloids Surf. B 126 (2015), 44–49.
38. [38] Li, Z., Yi, P.W., Sun, Q., Lei, H., Li Zhao, H., Zhu, Z.H., et al. Ultrasmall water-soluble and biocompatible magnetic iron oxide nanoparticles as positive and negative dual contrast agents. Adv. Funct. Mater. 22 (2012), 2387–2393.
39. [39] Holzer, W., Mauerer, M., Penzkofer, A., Szeimies, R.M., Abels, C., Landthaler, M., et al. Photostability and thermal stability of indocyanine green. J. Photochem. Photobiol. B 47 (1998), 155–164.
40. [40] Li, W., Peng, J., Tan, L., Wu, J., Shi, K., Qu, Y., et al. Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 Co-loaded micelles. Biomaterials 106 (2016), 119–133.
41. [41] Ji, J., Zhang, Y., Chen, W.R., Wang, X., DC vaccine generated by ALA-PDT-induced immunogenic apoptotic cells for skin squamous cell carcinoma. Oncoimmunology, 5, 2015.
42. [42] Qidwai, A., Khan, S., Md, S., Fazil, M., Baboota, S., Narang, J.K., et al. Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma. Drug Deliv. 23 (2016), 1476–1485.
43. [43] Huang, Y.Y., Vecchio, D., Avci, P., Yin, R., Garcia-Diaz, M., Hamblin, M.R., Melanoma resistance to photodynamic therapy: new insights. Biol. Chem. 394 (2013), 239–250.
44. [44] Barraud, L., Merle, P., Soma, E., Lefrancois, L., Guerret, S., Chevallier, M., et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J. Hepatol. 42 (2005), 736–743.